Wealth Effects »

Seelos Therapeutics Inc Class Equity shares owned by Wealth Effects

Quarter-by-quarter ownership of Seelos Therapeutics Inc Class Equity shares owned by Wealth Effects from 13F filings

Historical chart of Wealth Effects investment in Seelos Therapeutics Inc Class Equity

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Inc Class Equity held by Wealth Effects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Inc Class Equity by Wealth Effects

Quarter filed Position value Share count Share price at filing
2024-06-30 $32k 54k 0.60

More positions owned by Wealth Effects

Avadel Pharmaceuticals Com Shs (AVDL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
The Trade Desk Com Cl A (TTD)
Arrowhead Pharmaceuticals (ARWR)
Enovix Corp (ENVX)
Blackstone Group Inc Com Cl A (BX)
Eli Lilly & Co. (LLY)
Chevron Corporation (CVX)

View all positions for Wealth Effects

Top funds holding Seelos Therapeutics Inc Class Equity

AdvisorShares Investments
Wealth Effects
Morgan Stanley
Modera Wealth Management
Geode Capital Management
BlackRock
Tower Research Capital
Carmichael Hill & Associates
Jpmorgan Chase & Co
Bank of America Corporation
Group One Trading
Vermillion & White Wealth Management Group
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group

View all funds holding Seelos Therapeutics Inc Class Equity